Abstract:Background The transcription factor Spi-1 proto-oncogene (SPI1, also known as PU.1) is a key regulator of signal communication in the immune system and is essential for the development of myeloid cells and lymphocytes. However, the potential role of SPI1 in gastric cancer (GC) and the correlations between SPI1 and immune infiltration remain unclear. Methods In the present study, multiple databases including ONCOMINE, TIMER, Kaplan–Meier Plotter, and The Cancer Genome Atlas were used to explore the expression levels and prognostic value of SPI1 in GC. cBioPortal was used to explore the possible reasons for the increased expression of SPI1 in GC. The correlations between SPI1 expression and tumor-infiltrating immune cells (TICs) were analyzed using CIBERSORT and TIMER. Gene set enrichment analysis was used to determine the biological function of SPI1 in the development of GC. In addition, a risk signature based on SPI1-related immunomodulators was constructed to accurately evaluate the prognosis of patients with GC. The upregulation of SPI1 expression in GC was further confirmed through immunohistochemistry, western blotting, and real-time quantitative PCR (RT-qPCR) assay. Results The expression of SPI1 was increased significantly in GC according to multiple databases, and high expression of SPI1 was related to poor prognosis and progression of GC. The main factor influencing the high expression of SPI1 mRNA in GC may be diploidy, not DNA methylation. Moreover, immunohistochemistry, western blotting, and RT-qPCR assays also confirmed the upregulated expression of SPI1 in GC. CIBERSORT analysis revealed that SPI1 expression was correlated with seven types of TICs (naive B cells, resting memory CD4 T cells, activated memory CD4 T cells, activated natural killer cells, resting natural killer cells, M2 macrophages, and resting dendritic cells). Gene set enrichment analysis indicated that SPI1 might be related to immune activation in GC and participate in cell cycle regulation. In addition, based on SPI1-related immunomodulators, we developed multiple-gene risk prediction signatures and constructed a nomogram that can independently predict the clinical outcome of GC. Conclusion The results of the present study suggest that SPI1 has a critical role in determining the prognosis of GC patients and may be a potential immunotherapeutic target.

Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1

DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter

Research Progress on Relationship Between Transcription Factor Sp1 and Tumor

SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma

Differential phosphorylations of Spi-B and Spi-1 transcription factors

Spi-B can functionally replace PU.1 in myeloid but not lymphoid development

Crystal structure and functional characterization of the human RBM25 PWI domain and its flanking basic region.

Essential Role Of Spi-1-Like (Spi-1l) In Zebrafish Myeloid Cell Differentiation

Expression and Clinical Significance of Spi-B in B-cell Acute Lymphoblastic Leukemia

The Ets factor Spi-B is a direct critical target of the coactivator OBF-1

The ETS transcription factor Spi2 regulates hematopoietic cell development in zebrafish

Cloning, Characterization and Mapping of Human SPIN to Human Chromosome 9Q22.1–22.3

PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction

The Identification of Cdnas That Affect the Mitosis-to-interphase Transition in Schizosaccharomyces Pombe, Including Sbp1, Which Encodes a Spi1p-Gtp-binding Protein.

Molecular Cloning and Characterization of a Novel Splice Variant of Humanznf300gene, Which Expressed Highly in Testis

Pioneering, chromatin remodeling, and epigenetic constraint in early T-cell gene regulation by SPI1 (PU.1)

Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer

Molecular Cloning and Characterization of a Novel Human Gene (HSPBAP1) from Human Fetal Brain

Expression of a Novel Bhlh-Zip Gene in Human Testis

Secreted Phosphoprotein 1 As a Potential Prognostic and Immunotherapy Biomarker in Multiple Human Cancers

Decreased PU.1 expression in mature B cells induces lymphomagenesis